본문 바로가기
KERD
논문KCI 등재

The Factors Affecting the Relationship between Remission Status and Employment in Chronic Schizophrenia Patients

0

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류정신과학

초록

Objective Symptomatic remission have substantial effects in long-term schizophrenia outcome, but exact determinants of the employment. In this study, the relationship between employment and symptomatic remission in chronic schizophrenia patients and other factors related to employment were investigated. Methods 100 patients interviewed were evaluated by the Positive and Negative Syndrome Scale (PANSS), Functional Recovery Scale in Schizophrenia (FROGS), Global Assessment of Functioning (GAF), Quality of Life Scale (QoL) and Subjective Recovery Assessment Scale (SubRAS). Sociodemographic variables, clinical features, antipsychotic dose and past working history obtained from patient interviews were investigated. Results The patients of 40% who participate in the study were symptomatic remission, but only 53.5% of these patients weren’t employed. Young age, especially, -regardless of the onset of illness- working a job in the past, low and moderate use CPED (equivalent doses according to chlorpromazine), shorter disease duration, symptomatic remission was found to be closely related to employment. While QoL, FROGS, GAF, and SubRAS total scores of employment group were higher than the unemployment group, PANSS total scores in the unemployment group were higher than that of the employment group. There was a high correlation between the scales and employment status. Conclusion Employment status was closely related with the remission status. This study supports that symptomatic remission alone is not decisive for employment. It was found that younger age, past working history (before or after the disease), low and intermediate CPED antipsychotic use and shorter duration of disease were closely related to employment with symptomatic remission.

Abstract

Objective Symptomatic remission have substantial effects in long-term schizophrenia outcome, but exact determinants of the employment. In this study, the relationship between employment and symptomatic remission in chronic schizophrenia patients and other factors related to employment were investigated. Methods 100 patients interviewed were evaluated by the Positive and Negative Syndrome Scale (PANSS), Functional Recovery Scale in Schizophrenia (FROGS), Global Assessment of Functioning (GAF), Quality of Life Scale (QoL) and Subjective Recovery Assessment Scale (SubRAS). Sociodemographic variables, clinical features, antipsychotic dose and past working history obtained from patient interviews were investigated. Results The patients of 40% who participate in the study were symptomatic remission, but only 53.5% of these patients weren’t employed. Young age, especially, -regardless of the onset of illness- working a job in the past, low and moderate use CPED (equivalent doses according to chlorpromazine), shorter disease duration, symptomatic remission was found to be closely related to employment. While QoL, FROGS, GAF, and SubRAS total scores of employment group were higher than the unemployment group, PANSS total scores in the unemployment group were higher than that of the employment group. There was a high correlation between the scales and employment status. Conclusion Employment status was closely related with the remission status. This study supports that symptomatic remission alone is not decisive for employment. It was found that younger age, past working history (before or after the disease), low and intermediate CPED antipsychotic use and shorter duration of disease were closely related to employment with symptomatic remission.

참고문헌 (49)

  1. Andreasen NC, "Remission in schizophrenia : proposed criteria and rationale for consensus", Am J Psychiatry, 162, pp.441~449 (2005)
  2. Emsley R, "The concepts of remission and recovery in schizophrenia", Curr Opin Psychiatry, 24, pp.114~121 (2011)
  3. Lehman AF, "The well-being of chronic mental patients", Arch Gen Psychiatry, 40, pp.369~373 (1983)
  4. Wunderink L, "Recovery in remitted first-episode psychosis at 7 years of follow-up of an early dose reduction", discontinuation or maintenance treatment strategy long-term follow-up of a 2-year randomized clinical trial, 2013, pp.70, 913~920
  5. Karow A, "Remitted but still impaired? Symptomatic versus functional remission in patients with schizophrenia", Eur Psychiatry, 27, pp.401~405 (2012)
  6. Van Os J, "Standardized remission criteria in schizophrenia", Acta Psychiatr Scand, 113, pp.91~95 (2006)
  7. Boden R, "Association between symptomatic remission and functional outcome in first-episode schizophrenia", Schizophr Res, 107, pp.232~237 (2009)
  8. Robinson DG, "Symptomatic and functional recovery from a first episode of schizophrenia or schizoaffective disorder", Am J Psychiatry, 161, pp.473~479 (2004)
  9. Bobes J, "Recovery from schizophrenia : results from a 1-year follow-up observational study of patients in symptomatic remission", Schizophr Res, 115, pp.58~66 (2009)
  10. Carmona VR, "Employment outcomes for people with schizophrenia spectrum disorder : a meta-analysis of randomized controlled trials", Int J Occup Med Environ Health, 30, pp.345~366 (2017)
  11. Hasegawa T, "Identifying improvable employment-related factors in schizophrenia patients", Psychiatry Res, 266, pp.199~205 (2018)
  12. Bouwmans C, "Employment and the associated impact on quality of life in people diagnosed with schizophrenia", Neuropsychiatr Dis Treat, 11, pp.2125~2142 (2015)
  13. Salkever D, "The Economics of Gender and Mental Illness West York Shire", pp.109~131 (2004), The Emerald Group Publishing Limited
  14. Üçok A, "Employment and its relationship with functionality and quality of life in patients with schizophrenia: EGOFORS Study", Eur Psychiatry, 27, pp.422~425 (2012)
  15. Kopelowicz A, "Neurocognitive correlates of recovery from schizophrenia", Psychol Med, 35, pp.1165~1173 (2005)
  16. Evensen S, "Prevalence, Employment rate, and cost of schizophrenia in a high-income welfare society : a population-based study using comprehensive health and welfare registers", Schizophr Bull, 42, pp.476~483 (2016)
  17. Marwaha S, "Schizophrenia and employment – a review", Soc Psychiatry Psychiatr Epidemiol, 39, pp.337~349 (2004)
  18. Yüksel N, "Atipik Antipsikotikler", pp.813~814 (2010), Tuna Matbaacılık San
  19. Kay SR, "The positive and negative syndrome scale(PANSS)for schizophrenia", Schizophr Bull, 13, pp.261~276 (1987)
  20. Boyer L, "Validation of a functional remission threshold for the Functional Remission of General Schizophrenia(FROGS)scale", Compr Psychiatry, 54, pp.1016~1022 (2013)
  21. Aas IM, "Guidelines for rating Global Assessment of Functioning (GAF)", Ann Gen Psychiatry, 10, pp.2~ (2011)
  22. Heinrichs DW, "The quality of life scale : an instrument for rating the schizophrenic defıcit syndrome", Schizophr Bull, 10, pp.388~398 (1984)
  23. Yildiz M, "Development and validation of the Subjective Recovery Assessment Scale for patients with schizophrenia", Psychiatry Clin Psychopharmacol, 2, pp.163~169 (2018)
  24. Kostakoglu E, "Reliability and validity of the Turkish version of the Positive and Negative Syndrome Scale (PANSS)", Turk Psikol Derg, 14, pp.23~32 (1999)
  25. Emiroğlu B, "Validation of the Turkish version of the Functional Remission of General Schizophrenia (FROGS) scale", Arch Neuropsychiatry, 46(Suppl), pp.S15~S24 (2009)
  26. Soygür H, "Şizofreni hastaları için yaşam niteliği ölçeği: Güvenirlik ve yapısal geçerlik çalışması", Dusunen Adam J Psychiatry Neurol Sci, 13, pp.204~210 (2000)
  27. Endicott J, "The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance", Arch Gen Psychiatry, 33, pp.766~771 (1976)
  28. Kokaçya MH, "Symptomatic remission determines functional improvement and quality of life in schizophrenia", Noro Psikiyatr Ars, 53, pp.328~333 (2016)
  29. Yung AR, "Psychosis prediction : 12-month follow up of a high-risk("prodromal")group", Schizophr Res, 60, pp.21~32 (2003)
  30. Yung AR, "Risk factors for psychosis in an ultra-high-risk group : psychopathology and clinical features", Schizophr Res, 67, pp.131~142 (2004)
  31. Marwaha S, "Rates and correlates of employment in people with schizophrenia in the UK, France and Germany", Br J Psychiatry, 191, pp.30~37 (2007)
  32. Kaytaz BN, "Examınatıon of workıng lıfe In patıents wıth schızophrenıa and schızoaffectıve dısorder : a pılot study", J Health Sci Kocaeli Univ, 3, pp.13~17 (2017)
  33. Schennach R, "Functional outcomes in schizophrenia : employment status as a metric of treatment outcome", Curr Psychiatry Rep, 14, pp.229~236 (2012)
  34. Huber G, "A long-term follow-up study of schizophrenia : psychiatric course of illness and prognosis", Acta Psychiatr Scand, 52, pp.49~57 (1975)
  35. Yıldız M, "Demographic and clinical characteristics in schizophrenia : a multi center cross-sectional case record study", Türk Psikiyatri Dergisi, 21, pp.213~224 (2010)
  36. Muller P, "The social status of schizophrenic patients", Nervenarzt, 69, pp.204~209 (1998)
  37. Yong Chon Park, "Differences in High Dose Antipsychotic Prescriptions in Patients with Schizophrenia in Asian Countries", Areas: Findings from the REAP-AP Study, 2018, pp.15(10), 1007~1008[DOI]
  38. Tihonen J, "Mortality and cumulative exposure to antipsychotics, antidepressants, and benzodiazepine in patients with schizophrenia : an observational follow-up study", Am J Psychiatry, 173, pp.600~606 (2016)
  39. Nuechterlein KH, "Neurocognitive predictors of work outcome in recentonset schizophrenia", Schizophr Bull, 37(Suppl 2), pp.S33~S40 (2011)
  40. Sakurai H, "Dopamine D2 receptor occupancy and cognition in schizophrenia : analysis of the CATIE data", Schizophr Bull, 39, pp.564~574 (2013)
  41. Takeuchi H, "Effects of risperidone and olanzapine dose reduction on cognitive function in stable patients with schizophrenia : an open-label, randomized, controlled, pilot study", Schizophr Bull, 39, pp.993~998 (2013)
  42. McGurk SR, "Cognitive functioning, symptoms, and work in sup-ported employment : a review and heuristic model", Schizophr Res, 70, pp.147~173 (2004)
  43. Mueser KT, "Work and non-vocational domains of functioning in persons with severe mental ill-ness : a longitudinal analysis", Nerv Ment Dis, 185, pp.419~426 (1997)
  44. Kilian R, "The relationships between employment, clinical status, and psychiatric hospitalisation in patients with schizophrenia receiving either IPS or a conventional vocational rehabilitation programme", Soc Psychiatry Psychiatr Epidemiol, 47, pp.1381~1389 (2012)
  45. Zaprutko T, "Schizophrenia and employment : evaluation from professionals point of view", Psychiatr Q, 86, pp.569~579 (2015)
  46. Martini LC, "Schizophrenia and work : aspects related to job acquisition in a follow-up study", Rev Bras Psiquiatr, 40, pp.35~40 (2018)
  47. Kukla M, "Strong subjective recovery as a protective factor against the effects of positive symptoms on quality of life outcomes in schizophrenia", Compr Psychiatry, 55, pp.1363~1368 (2014)

관련 논문AI추천

이 간행물의 다른 논문 (10건)